(Q34754682)

4 August 2017

Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates (English)

1 reference

4 August 2017

0 references

3

Benjamin EJ

1 reference

4 August 2017

1

Kannel WB

1 reference

4 August 2017

4

Levy D

1 reference

4 August 2017

2

Wolf PA

1 reference

PubMed ID

9809895

4 August 2017

language of work or name

English

0 references

publication date

1 October 1998

1 reference

American Journal of Cardiology

4 August 2017

1 reference

4 August 2017

82

1 reference

4 August 2017

2N-9N

1 reference

4 August 2017

8A

1 reference

Coronary heart disease and atrial fibrillation: the Framingham Study

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

Chronic atrial fibrillation--epidemiologic features and 14 year follow-up: a case control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

Atrial fibrillation and mortality in an elderly population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

Secular trends in the prevalence of atrial fibrillation: The Framingham study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The fiamingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

Non-rheumatic atrial fibrillation as a risk factor for stroke.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

Epidemiologic features of chronic atrial fibrillation: the Framingham study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

Relationship of Stroke to Other Cardiovascular Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

Embolic complications in paroxysmal atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

Thromboembolism in patients with atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

Duration of atrial fibrillation and imminence of stroke: the Framingham study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

Risk factors for systemic embolism in patients with paroxysmal atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

Atrial fibrillation after acute stroke.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

Newly Diagnosed Atrial Fibrillation and Acute Stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

Risk factors for stroke and other embolic events in patients with nonrheumatic atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

Stroke severity in atrial fibrillation. The Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

Assessment of left atrial function in patients with hypertensive heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

Clinical and prognostic significance of atrial fibrillation in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

Impact of atrial fibrillation on the in-hospital and long-term survival of patients with acute myocardial infarction: a community-wide perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

Incidence and prognostic significance of chronic atrial fibrillation among 5,839 consecutive patients with acute myocardial infarction. The SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

Acute stroke with atrial fibrillation. The Copenhagen Stroke Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

Prognostic factors in first-ever stroke in the carotid artery territory seen within 6 hours after onset.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

Risk of stroke in non-rheumatic atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

Longitudinal survey of ischaemic heart disease in randomly selected sample of older population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

Stroke Prevention in Atrial Fibrillation Study. Final results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900583-9

10.1016/S0002-9149(98)00583-9

7 January 2021

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

9809895